agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
115.66
+5.36 (4.86%)
At close: Nov 13, 2026, 4:00 PM EST
115.65
-0.01 (-0.01%)
After-hours: Nov 13, 2026, 7:47 PM EST
agilon health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,996 | 5,921 | 6,048 | 4,307 | 2,385 | 1,518 |
Other Revenue | 7.89 | 11.24 | 12.82 | 9.01 | 3.33 | 3.17 |
| 6,004 | 5,933 | 6,061 | 4,316 | 2,388 | 1,521 | |
Revenue Growth | 2.02% | -2.11% | 40.41% | 80.74% | 56.96% | 24.88% |
Cost of Revenue | 5,825 | 6,093 | 6,056 | 4,247 | 2,277 | 1,456 |
Gross Profit | 179.47 | -160.02 | 4.84 | 69.67 | 111.36 | 65.74 |
Selling, General & Admin | 251.7 | 232.46 | 264.34 | 285.57 | 205.32 | 422.1 |
Operating Expenses | 279.06 | 261.06 | 288.8 | 301.62 | 214.27 | 432.59 |
Operating Income | -99.59 | -421.08 | -283.96 | -231.95 | -102.91 | -366.84 |
Interest Expense | -6.88 | -6.64 | -6.18 | -6.66 | -4.48 | -6.15 |
Interest & Investment Income | 10.6 | 14.7 | 19.2 | 27.9 | 14.5 | - |
Earnings From Equity Investments | -29.89 | -1.84 | 14.99 | 16.49 | 10.72 | -6.77 |
Other Non Operating Income (Expenses) | 79 | 52.92 | 15.29 | -0.06 | -0.57 | 2.18 |
EBT Excluding Unusual Items | -46.77 | -361.94 | -240.65 | -194.27 | -82.74 | -377.58 |
Impairment of Goodwill | -24.1 | -24.1 | - | - | - | - |
Asset Writedown | -11.99 | -11.99 | -3.6 | - | - | - |
Other Unusual Items | -18.27 | -6.08 | -4.58 | -0.19 | -7.93 | -5.4 |
Pretax Income | -101.12 | -404.1 | -248.83 | -194.46 | -90.67 | -382.98 |
Income Tax Expense | 4.98 | 1.25 | 1.45 | 0.79 | 1.64 | 0.89 |
Earnings From Continuing Operations | -106.1 | -405.35 | -250.28 | -195.25 | -92.31 | -383.86 |
Earnings From Discontinued Operations | 19 | 14 | -9.82 | -67.55 | -14.55 | -22.93 |
Net Income to Company | -87.1 | -391.35 | -260.1 | -262.8 | -106.86 | -406.79 |
Minority Interest in Earnings | - | - | -0.05 | 0.21 | 0.31 | 0.3 |
Net Income | -87.1 | -391.35 | -260.15 | -262.6 | -106.55 | -406.49 |
Net Income to Common | -87.1 | -391.35 | -260.15 | -262.6 | -106.55 | -406.49 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 17 | 17 | 16 | 16 | 16 | 15 |
Shares Outstanding (Diluted) | 17 | 17 | 16 | 16 | 16 | 15 |
Shares Change | 0.83% | 0.73% | 0.50% | 0.19% | 9.45% | 15.29% |
EPS (Basic) | -5.22 | -23.63 | -15.83 | -16.05 | -6.53 | -27.25 |
EPS (Diluted) | -5.23 | -23.63 | -15.83 | -16.05 | -6.53 | -27.25 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -17.01 | -119.01 | -71.03 | -172.03 | -146.23 | -154.72 |
Free Cash Flow Per Share | -1.02 | -7.19 | -4.32 | -10.52 | -8.96 | -10.37 |
Gross Margin | 2.99% | -2.70% | 0.08% | 1.61% | 4.66% | 4.32% |
Operating Margin | -1.66% | -7.10% | -4.69% | -5.37% | -4.31% | -24.11% |
Profit Margin | -1.45% | -6.60% | -4.29% | -6.08% | -4.46% | -26.72% |
Free Cash Flow Margin | -0.28% | -2.01% | -1.17% | -3.99% | -6.12% | -10.17% |
EBITDA | -85.93 | -406.18 | -269.99 | -222.1 | -93.96 | -356.36 |
EBITDA Margin | -1.43% | -6.85% | -4.46% | -5.15% | -3.93% | -23.42% |
D&A For EBITDA | 13.66 | 14.89 | 13.96 | 9.84 | 8.95 | 10.48 |
EBIT | -99.59 | -421.08 | -283.96 | -231.95 | -102.91 | -366.84 |
EBIT Margin | -1.66% | -7.10% | -4.69% | -5.37% | -4.31% | -24.11% |
Revenue as Reported | 6,004 | 5,933 | 6,061 | 4,316 | 2,388 | 1,521 |